TYPE 1 DIABETES MELLITUS
Clinical trials for TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug dosing study aims to preserve insulin in type 1 diabetes
Disease control TerminatedThis study tested four different doses of a drug called siplizumab in people aged 8 to 45 who were diagnosed with type 1 diabetes within the last 18 months. The goal was to find a safe dose that could help preserve the body's ability to produce insulin by changing certain immune …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
New pill aims to revive Insulin-Making cells in type 1 diabetes
Disease control TerminatedThis study tested an experimental drug called BMF-219 in adults with type 1 diabetes. The goal was to see if it could help the body produce more of its own insulin, reducing the need for injected insulin. The trial was stopped early, so results are limited.
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
AI-Powered diabetes coach could replace some doctor visits
Disease control TerminatedThis study tested a software called DreaMed Advisor Pro that automatically analyzes blood sugar and insulin pump data to suggest insulin dose adjustments. Researchers wanted to see if these suggestions could be sent directly to patients without a doctor's review. The study includ…
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Rabin Medical Center • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
Tablet teaching for diabetes: a High-Tech hope that fizzled
Knowledge-focused TerminatedThis study tested whether using a bedside tablet with educational modules helps people newly diagnosed with type 1 diabetes learn more about their condition compared to standard paper-based education. The study planned to enroll 28 participants but was terminated early. The main …
Matched conditions: TYPE 1 DIABETES MELLITUS
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC